Moderna and Merck have reported promising results for their personalised mRNA cancer vaccine, Intismeran, which reduced melanoma recurrence and spread in late-stage trials. The interim
U.S. President Donald Trump aims to revive the Keystone XL pipeline expansion project in connection with a forthcoming trade deal with Canada. This announcement highlights